Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Bostwick

Showing results (11-20 of 120) with videos related to

Pageof 12
Sort By:
European Urology|January 31, 2006
Prostate biopsy and optimization of cancer yieldDavid G Bostwick, Isabelle Meiers
Best Practice & Research. Clinical Endocrinology & Metabolism|May 13, 2008
Androgen deprivation therapy for precancerous lesions of the prostateDavid Hull, David G Bostwick
Archives of Pathology & Laboratory Medicine|May 23, 2007
Diagnosis of prostatic carcinoma after therapyDavid G Bostwick, Isabelle Meiers
BJU International|April 13, 2013
Significance of the TMPRSS2:ERG gene fusion in prostate cancerDeloar Hossain, David G Bostwick
Archives of Pathology & Laboratory Medicine|July 13, 2006
Atypical small acinar proliferation in the prostate: clinical significance in 2006David G Bostwick, Isabelle Meiers
Annals of Diagnostic Pathology|June 15, 2013
Adequate histologic sectioning of prostate needle biopsiesDavid G Bostwick, Hillel Kahane
Reviews in Urology|October 7, 2008
Prostate Cancer Specificity of PCA3 Gene Testing: Examples from Clinical PracticeLeonard S Marks, David G Bostwick
BJU International|June 26, 2004
'Vanishing' prostate cancer in radical prostatectomy specimens: incidence and long-term follow-up in 38 casesDavid G Bostwick, Kathleen C Bostwick
Clinics in Laboratory Medicine|April 26, 2005
Tubulocystic carcinoma, mucinous tubular and spindle cell carcinoma, and other recently described rare renal tumorsGregory T MacLennan, David G Bostwick
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2009
Three-dimensional prostate mapping biopsy has a potentially significant impact on prostate cancer managementGary Onik, Matthew Miessau, David G Bostwick
Pageof 12

Showing results (11-20 of 120) with videos related to

Sort By:
Pageof 12
European Urology|January 31, 2006
Prostate biopsy and optimization of cancer yieldDavid G Bostwick, Isabelle Meiers
Best Practice & Research. Clinical Endocrinology & Metabolism|May 13, 2008
Androgen deprivation therapy for precancerous lesions of the prostateDavid Hull, David G Bostwick
Archives of Pathology & Laboratory Medicine|May 23, 2007
Diagnosis of prostatic carcinoma after therapyDavid G Bostwick, Isabelle Meiers
BJU International|April 13, 2013
Significance of the TMPRSS2:ERG gene fusion in prostate cancerDeloar Hossain, David G Bostwick
Archives of Pathology & Laboratory Medicine|July 13, 2006
Atypical small acinar proliferation in the prostate: clinical significance in 2006David G Bostwick, Isabelle Meiers
Annals of Diagnostic Pathology|June 15, 2013
Adequate histologic sectioning of prostate needle biopsiesDavid G Bostwick, Hillel Kahane
Reviews in Urology|October 7, 2008
Prostate Cancer Specificity of PCA3 Gene Testing: Examples from Clinical PracticeLeonard S Marks, David G Bostwick
BJU International|June 26, 2004
'Vanishing' prostate cancer in radical prostatectomy specimens: incidence and long-term follow-up in 38 casesDavid G Bostwick, Kathleen C Bostwick
Clinics in Laboratory Medicine|April 26, 2005
Tubulocystic carcinoma, mucinous tubular and spindle cell carcinoma, and other recently described rare renal tumorsGregory T MacLennan, David G Bostwick
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2009
Three-dimensional prostate mapping biopsy has a potentially significant impact on prostate cancer managementGary Onik, Matthew Miessau, David G Bostwick
Pageof 12